2015
DOI: 10.1016/j.jmig.2015.04.011
|View full text |Cite
|
Sign up to set email alerts
|

A Randomized Controlled Trial on the Efficacy and Safety of a New Crosslinked Hyaluronan Gel in Reducing Adhesions after Gynecologic Laparoscopic Surgeries

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 35 publications
(17 citation statements)
references
References 50 publications
0
17
0
Order By: Relevance
“…Hyaluronic acid (HA), either native or crosslinking modified, has been broadly used to prevent postoperative adhesion with varies level of successes [ 4 6 ]. HA is a non-sulfated glycosaminoglycan consisting of repeated disaccharide units (a-1,4-D-glucuronic acid and β-1,3- N -acetyl-D-glucosamine) and presents in all connective tissues as a major constituent of extracellular matrix.…”
Section: Introductionmentioning
confidence: 99%
“…Hyaluronic acid (HA), either native or crosslinking modified, has been broadly used to prevent postoperative adhesion with varies level of successes [ 4 6 ]. HA is a non-sulfated glycosaminoglycan consisting of repeated disaccharide units (a-1,4-D-glucuronic acid and β-1,3- N -acetyl-D-glucosamine) and presents in all connective tissues as a major constituent of extracellular matrix.…”
Section: Introductionmentioning
confidence: 99%
“…So, modification might be one of the effective ways to prolong the half-life of HA, such as crosslinking modification. In fact, CHAG applied in this paper had been reported to significantly reduce adhesion in abdominopelvic cavity after gynecological laparoscopic surgeries [ 12 , 34 ]. However, since there was no data elucidating the effect of CHAG on the cells of gynecologic tumor, it is still unclear whether CHAG is safe enough for preventing postoperative adhesion in pelvic surgery of this kind of tumor.…”
Section: Discussionmentioning
confidence: 99%
“…Clinical research showed that injection of hydrogel containing HA and chitosan could serve as an ideal barrier to prevent postoperative tissue adhesion [ 11 ]. A randomly-controlled trial reported that a new crosslinked gel (CHAG) was efficient and safe in reducing adhesions after gynecologic laparoscopic surgeries in clinical practice [ 12 ]. Additionally, absorbable auto-crosslinked hyaluronan gel could prevent intrauterine adhesion (IUA), decrease adhesion severity, and improve menopause postoperatively, indicating that this absorbable gel could be proposed as a barrier for preventing IUA after intrauterine procedures [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…A new crosslinked hyaluronan gel was also evaluated for its ability to reduce postoperative adhesions in a randomized study comprising of 215 Chinese women who underwent surgical laparoscopy for the initial removal of existing endometrial lesions. The study found that use of the gel decreased the number and severity of post-operative adnexal and abdominopelvic adhesions in patients, thus potentially reducing the incidence of disease recurrence [ 60 ]. In this study, the authors propose that since hyaluron has a sufficiently long elimination half -life (metabolic clearance is slowed down by its ability to cross-link), it is able to persist within the body for the time window during which new adhesions are formed.…”
Section: Introductionmentioning
confidence: 99%